Palvella Therapeutics (PVLA) Treasury Shares (2014 - 2024)

Palvella Therapeutics (PVLA) has reported Treasury Shares for 5 consecutive years, with $15.4 million the latest figure, recorded in Q3 2024.

• In Q3 2024, Treasury Shares changed N/A year-over-year to $15.4 million; the TTM figure through Sep 2024 stood at $15.4 million (changed N/A YoY), while the FY2023 annual figure was $15.4 million, changed 0.0% from the prior year.
• Treasury Shares held at $15.4 million in Q3 2024 per PVLA's latest filing, from $15.4 million in the prior quarter.
• Across five years, Treasury Shares topped out at $15.4 million in Q4 2022 and bottomed at $15.4 million in Q4 2022.
• Historically, Treasury Shares has averaged $15.4 million across 3 years, with a median of $15.4 million in 2022.
• On a YoY basis, Treasury Shares climbed as much as 0.0% in 2023 and fell as far as 0.0% in 2023.
• Palvella Therapeutics' Treasury Shares stood at $15.4 million in 2022, then changed by 0.0% to $15.4 million in 2023, then changed by 0.0% to $15.4 million in 2024.
• Business Quant data shows PVLA's Treasury Shares at $15.4 million in Q3 2024, $15.4 million in Q2 2024, and $15.4 million in Q1 2024.